Swiftscale Biologics
South San Francisco
About Swiftscale Biologics
Swiftscale Biologics uses cell-free protein synthesis to enable the next generation of protein therapeutics.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: Less than $1M
- Total funding: $15.0M
- Funding stage: M&A
- Last round: Seed (Jun 2020)
- Website: swiftscalebio.com
Industries & Categories
Big Data, Bioinformatics, Biopharma, Biotechnology, Therapeutics
Canonical: https://fsome.com/organization/swiftscale-biologics-1292 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.